$PLTR
Palantir Technologies Inc Stock $pltr

$pltr Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000119312521159222 Filed on May 12, 2021

Income Statement

Concept	2021 Q1	2020 Q4	2020 Q1
Revenue	$341.2M	$322.1M	$229.3M
YoY Change	48.8%
Cost Of Revenue	$74.11M	$70.50M	$64.29M
YoY Change	15.27%
Gross Profit	$267.1M	$251.6M	$165.0M
YoY Change	61.86%
Gross Profit Margin	78.28%	78.11%	71.96%
Selling, General & Admin	$282.7M	$314.0M	$169.4M
YoY Change	66.85%
% of Gross Profit	105.82%	124.8%	102.66%
Research & Development	$98.47M	$94.10M	$65.80M
YoY Change	49.65%
% of Gross Profit	36.86%	37.4%	39.87%
Depreciation & Amortization	$3.237M	$3.600M	$3.671M
YoY Change	-11.82%	-38.98%
% of Gross Profit	1.21%	1.43%	2.22%
Operating Expenses	$381.1M	$408.2M	$235.2M
YoY Change	62.04%
Operating Profit	-$114.0M	-$156.6M	-$70.19M
YoY Change	62.45%
Interest Expense	$1.840M	-$1.400M	$4.594M
YoY Change	-59.95%
% of Operating Profit
Other Income/Expense, Net	-$4.894M	$2.100M	$6.100M
YoY Change	-180.23%
Pretax Income	-$120.4M	-$155.9M	-$51.72M
YoY Change	132.75%
Income Tax	$3.100M	-$7.600M	$2.557M
% Of Pretax Income
Net Earnings	-$123.5M	-$148.3M	-$54.27M
YoY Change	127.5%
Net Earnings / Revenue	-36.18%	-46.04%	-23.67%
Basic Earnings Per Share	-$0.07		-$0.09
Diluted Earnings Per Share	-$0.07	-$82.75K	-$0.10
COMMON SHARES
Basic Shares Outstanding	1.821B shares		591.9M
Diluted Shares Outstanding	1.821B shares		594.4M

Balance Sheet

Concept	2021 Q1	2020 Q4	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.339B	$2.011B
YoY Change
Cash & Equivalents	$2.339B	$2.011B	$809.5M
Short-Term Investments
Other Short-Term Assets	$98.90M	$89.20M
YoY Change
Inventory
Prepaid Expenses
Receivables	$151.4M	$156.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.590B	$2.257B
YoY Change		85.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.38M	$29.54M
YoY Change		-6.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$111.8M	$106.9M
YoY Change		37.83%
Total Long-Term Assets	$424.5M	$433.1M
YoY Change		14.01%
TOTAL ASSETS
Total Short-Term Assets	$2.590B	$2.257B
Total Long-Term Assets	$424.5M	$433.1M
Total Assets	$3.014B	$2.691B
YoY Change		68.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.23M	$16.36M
YoY Change		-68.38%
Accrued Expenses	$181.6M	$158.5M
YoY Change		25.21%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$667.6M	$603.8M
YoY Change		-17.13%
LONG-TERM LIABILITIES
Long-Term Debt	$198.2M	$198.0M
YoY Change		-50.01%
Other Long-Term Liabilities	$4.236M	$4.316M
YoY Change		-94.48%
Total Long-Term Liabilities	$202.4M	$202.3M
YoY Change		-57.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$667.6M	$603.8M
Total Long-Term Liabilities	$202.4M	$202.3M
Total Liabilities	$1.208B	$1.168B
YoY Change		-19.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.089B	-$4.965B
YoY Change		30.7%
Common Stock	$1.860M	$1.792M
YoY Change		204.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$0.00
YoY Change		-100.0%
Treasury Stock Shares		$0.00
Shareholders Equity	$1.806B	$1.523B	-$1.977B
YoY Change
Total Liabilities & Shareholders Equity	$3.014B	$2.691B
YoY Change		68.79%

Cashflow Statement

Concept	2021 Q1	2020 Q4	2020 Q1
OPERATING ACTIVITIES
Net Income	-$123.5M	-$148.3M	-$54.27M
YoY Change	127.5%
Depreciation, Depletion And Amortization	$3.237M	$3.600M	$3.671M
YoY Change	-11.82%	-38.98%
Cash From Operating Activities	$116.9M	-$18.30M	-$287.2M
YoY Change	-140.7%	-110.45%
INVESTING ACTIVITIES
Capital Expenditures	$708.0K	-$4.700M	$3.016M
YoY Change	-76.53%	-18.97%
Acquisitions
YoY Change
Other Investing Activities		-$200.0K
YoY Change		-97.75%
Cash From Investing Activities	-$708.0K	-$4.900M	-$3.016M
YoY Change	-76.53%	-66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$3.777M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$206.4M	219.2M	2.494M
YoY Change	8174.02%	-2.49%
NET CHANGE
Cash From Operating Activities	$116.9M	-18.30M	-287.2M
Cash From Investing Activities	-$708.0K	-4.900M	-3.016M
Cash From Financing Activities	$206.4M	219.2M	2.494M
Net Change In Cash	$320.3M	196.0M	-289.3M
YoY Change	-210.71%	-49.12%
FREE CASH FLOW
Cash From Operating Activities	$116.9M	-$18.30M	-$287.2M
Capital Expenditures	$708.0K	-$4.700M	$3.016M
Free Cash Flow	$116.2M	-$13.60M	-$290.2M
YoY Change	-140.03%	-107.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2011323000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	37285000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	156932000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	51889000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	2257429000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29541000
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	79538000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	106921000
CY2020Q4	us-gaap	Assets Assets	2690504000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16358000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	158546000
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	229327000
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	64294000
CY2020Q1	us-gaap	Gross Profit GrossProfit	165033000
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	98653000
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	189520000
CY2020Q4	pltr	Customer Deposit Current CustomerDepositCurrent	210320000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	603823000
CY2020Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	50525000
CY2020Q4	pltr	Customer Deposit Noncurrent CustomerDepositNoncurrent	81513000
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	197977000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4316000
CY2020Q4	us-gaap	Liabilities Liabilities	1167954000
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-13695000
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6100000
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51717000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2557000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-54274000
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53248000
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	51403000
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	65800000
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70765000
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	235218000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-70185000
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3267000
CY2020Q1	us-gaap	Interest Expense InterestExpense	4594000
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7974000
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	8403000
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-40790000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1026000
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-39368000
CY2020Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	8599000
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-132077000
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-287184000
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3016000
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3016000
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6710000
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3777000
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2494000
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1792000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6488857000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2745000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4965354000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2690504000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1522550000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-1980642000
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3777000
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6710000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54238000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-1976619000
CY2020Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-439000
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1627000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-289333000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1401962000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1112629000
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7665000
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	1774000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	809530000
CY2020Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	65795000
CY2020Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	237304000
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1149880000
CY2020Q1	pltr	Increase Decrease In Operating Lease Liability Current And Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityCurrentAndNoncurrent	-16251000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	117940000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	88399000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	85466000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	73080000
CY2020Q1	us-gaap	Depreciation Depreciation	3700000
CY2020Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	116800000
CY2021Q1	pltr	Minimum Ownership Threshold MinimumOwnershipThreshold	100000000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	535767000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.12
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y11M26D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9340245000
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	477577000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8069476000
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P8Y1M2D
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	Palantir Technologies Inc.
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001321655
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2021Q1	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.001 per share
CY2021Q1	dei	Trading Symbol TradingSymbol	PLTR
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	217075000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	29079000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	229800000
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000000
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000000
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1026000
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	625900000
CY2021Q1	us-gaap	Depreciation Depreciation	3200000
CY2021Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	200000000
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	2023000
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0
CY2020Q3	pltr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Shares Issuable Upon Vesting ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesIssuableUponVesting	1.5
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3671000
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54107000
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-13695000
CY2020Q1	pltr	Noncash Operating Lease Cost NoncashOperatingLeaseCost	10160000
CY2020Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	514000
CY2021Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1229912000
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3610000
CY2021Q1	us-gaap	Interest Expense InterestExpense	1840000
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4894000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-120372000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3102000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-123474000
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	208860000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	194397000
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3610000
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.50
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	113513000
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	68090000
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	91570000
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	200000000
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1815000
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y29D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y10M6D
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	22701005000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	22701005000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2339437000
CY2021Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	37106000
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	151400000
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	61755000
CY2021Q1	us-gaap	Assets Current AssetsCurrent	2589698000
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27378000
CY2021Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	71933000
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	213331000
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	111845000
CY2021Q1	us-gaap	Assets Assets	3014185000
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	17234000
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	181603000
CY2021Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	186498000
CY2021Q1	pltr	Customer Deposit Current CustomerDepositCurrent	250181000
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	32110000
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	667626000
CY2021Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	44998000
CY2021Q1	pltr	Customer Deposit Noncurrent CustomerDepositNoncurrent	70768000
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	198185000
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	222429000
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4236000
CY2021Q1	us-gaap	Liabilities Liabilities	1208242000
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	1860000
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6892046000
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	865000
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5088828000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1805943000
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3014185000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	341234000
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	74111000
CY2021Q1	us-gaap	Gross Profit GrossProfit	267123000
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	136097000
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	98471000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	146569000
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	381137000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-114014000
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	376000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-119864000
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3237000
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	44488000
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-11952000
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	20825000
CY2021Q1	pltr	Increase Decrease In Operating Lease Liability Current And Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityCurrentAndNoncurrent	-7132000
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	116881000
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	708000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	193731000
CY2021Q1	pltr	Noncash Operating Lease Cost NoncashOperatingLeaseCost	6477000
CY2021Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	771000
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4480000
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9753000
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	4865000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	51000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-708000
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	208860000
CY2021Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2506000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	206354000
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2197000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	320330000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2128146000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2448476000
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	878000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1662000
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	193731000
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	54107000
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	55301000
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.78
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2889000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	5.16
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.39
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	259517000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.67
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	5093003000
CY2020Q1	us-gaap	Dilutive Securities DilutiveSecurities	-7773000
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	552400000
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-123474000
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-62047000
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-123474000
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-54274000
CY2021Q1	us-gaap	Dilutive Securities DilutiveSecurities	0
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	591850000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1821158000
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	594363000
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1480368000
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	670378000
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	531900000
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	169500000
CY2020Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	181200000
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1860607000
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1792140000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1860607000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1792140000
CY2021Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1. Organization </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-align:justify;"><div style="display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Palantir Technologies Inc. (including its subsidiaries, “Palantir,” or “the Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms, Palantir Gotham and Palantir Foundry, that serve as the central operating systems for its customers. </div></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-align:justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-align:justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts, the valuation of deferred tax assets and uncertain tax positions, collectability of accounts receivable, useful lives of tangible assets, and the incremental borrowing rate for operating leases. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations. </div></div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentrations of Credit Risk and Other Concentrations </div></div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-align:justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-align:justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of March 31, 2021 and December 31, 2020 were $151.4 million and $156.9 million, respectively. Customer G represented 14% and 13% of total accounts receivable as of March 31, 2021 and December 31, 2020, respectively. No other customer represented more than 10% of total accounts receivable as of March 31, 2021 and December 31, 2020. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of March 31, 2021 and December 31, 2020, the Company had not experienced any significant losses on its accounts receivable. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-align:justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended March 31, 2021, no customer represented more than 10% of total revenue. For the three months ended March 31, 2020, Customer F, which is in the government operating segment, represented 12% of total revenue and Customer A, which is in the commercial operating segment, represented 11% of total revenue. No other customer represented more than 10% of total revenue for the three months ended March 31, 2020. </div></div></div> <div style="font-family: "times new roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-align:justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company relies on the technology, infrastructure, and software applications, including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">software-as-a-service</div></div></div> offerings, of third parties in order to host or operate certain key products and functions of its business. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1	pltr	Disclosure Of Recently Adopted Accounting Pronouncements DisclosureOfRecentlyAdoptedAccountingPronouncements	<div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Recently Adopted Accounting Pronouncements </div></div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-align:justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Simplifying the Accounting for Income Taxes (Topic 740) </div>as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> as of January 1, 2021 using transition methods allowed under each aspect of the guidance. The adoption of the standard did not have a material impact on the Company’s condensed consolidated financial statements. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1	pltr	Service Credit Utilized ServiceCreditUtilized	6700000
CY2020Q1	pltr	Service Credit Utilized ServiceCreditUtilized	300000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1821158000
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	118948000

Files In Submission

Name	View Source	Status
0001193125-21-159222-index-headers.html	Edgar Link	pending
0001193125-21-159222-index.html	Edgar Link	pending
0001193125-21-159222.txt	Edgar Link	pending
0001193125-21-159222-xbrl.zip	Edgar Link	pending
d158374d10q.htm	Edgar Link	pending
d158374dex311.htm	Edgar Link	pending
d158374dex312.htm	Edgar Link	pending
d158374dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pltr-20210331.xml	Edgar Link	completed
pltr-20210331.xsd	Edgar Link	pending
pltr-20210331_cal.xml	Edgar Link	unprocessable
pltr-20210331_def.xml	Edgar Link	unprocessable
pltr-20210331_lab.xml	Edgar Link	unprocessable
pltr-20210331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLTR
Palantir Technologies Inc Stock $pltr

2021 Q1 Form 10-Q Financial Statement

#000119312521159222 Filed on May 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLTR Palantir Technologies Inc Stock $pltr

2021 Q1 Form 10-Q Financial Statement

#000119312521159222 Filed on May 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLTR
Palantir Technologies Inc Stock $pltr